tiprankstipranks
Trending News
More News >
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
Advertisement

Zevra Therapeutics (ZVRA) Technical Analysis

Compare
943 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Zevra Therapeutics’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is -0.55, suggesting Zevra Therapeutics is a Buy.
Zevra Therapeutics’s (ZVRA) 20-Day exponential moving average is 9.34, while Zevra Therapeutics’s (ZVRA) share price is $8.33, making it a Sell.
Zevra Therapeutics’s (ZVRA) 50-Day exponential moving average is 9.80, while Zevra Therapeutics’s (ZVRA) share price is $8.33, making it a Sell.

Zevra Therapeutics (ZVRA) Pivot Points

Sep 10, 2025, 07:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.47
7.89
8.11
8.53
8.75
9.17
9.39
Fibonacci
7.89
8.13
8.29
8.53
8.77
8.93
9.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Sep 10, 2025, 07:39 AM
Period
Simple
Exponential
MA5
8.67Sell
8.60Sell
MA10
8.96Sell
8.88Sell
MA20
9.24Sell
9.34Sell
MA50
10.52Sell
9.80Sell
MA100
9.43Sell
9.54Sell
MA200
8.77Sell
9.04Sell
Zevra Therapeutics’s (ZVRA) 10-Day exponential moving average is 8.88, while Zevra Therapeutics’s (ZVRA) share price is $8.33, making it a Sell.
Zevra Therapeutics’s (ZVRA) 100-Day exponential moving average is 9.54, while Zevra Therapeutics’s (ZVRA) share price is $8.33, making it a Sell.
Zevra Therapeutics’s (ZVRA) stock price is $8.33 and Zevra Therapeutics’s (ZVRA) 50-day simple moving average is 10.52, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) stock price is $8.33 and Zevra Therapeutics’s (ZVRA) 100-day simple moving average is 9.43, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) stock price is $8.33 and Zevra Therapeutics’s (ZVRA) 200-day simple moving average is 8.77, creating a Sell signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Sep 10, 2025, 07:39 AM
Name
Value
Implied Action
RSI (14)
27.60
Buy
STOCH (9,6)
16.48
Buy
STOCHRSI (14)
9.66
Buy
MACD (12,26)
-0.55
Buy
ADX (14)
29.86
Neutral
Williams %R
-92.38
Buy
CCI (14)
-192.44
Buy
ATR (14)
0.50
-
Ultimate Oscillator
37.04
Neutral
ROC
-8.78
Sell
Zevra Therapeutics’s (ZVRA) Relative Strength Index (RSI) is 27.60, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) Trend Strength Indicator (ADX) is 29.86, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Commodity Channel Index (CCI) is -192.44, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) Price Rate of Change (ROC) is -8.78, creating a Sell signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Sell.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 27.60, which suggests ZVRA is a Buy.
      What is ZVRA’s MACD?
      ZVRA’s MACD is -0.55, which suggests ZVRA is a Buy.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 8.67, which suggests ZVRA is a Sell.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 9.24, which suggests ZVRA is a Sell.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 10.52, which suggests ZVRA is a Sell.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 8.77, which suggests ZVRA is a Sell.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -92.38, which suggests ZVRA is a Buy.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is -192.44, which suggests ZVRA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis